Journal of the American Society of Nephrology, Vol 5, 36-46, Copyright © 1994 by American Society of Nephrology

REGULAR ARTICLES

Impaired function of platelet membrane glycoprotein IIb-IIIa in end- stage renal disease

MP Gawaz, G Dobos, M Spath, P Schollmeyer, HJ Gurland and SK Mujais
Department Medical Klinik I, Klinikum Grosshadern, University of Munich, Germany.

Impaired platelet function and a bleeding tendency are well-recognized complications of chronic renal failure. Because the fibrinogen receptor GPIIb-IIIa plays a central role in platelet aggregation and adhesion to the subendothelium, it was reasoned that a defect in this receptor may underlie the impaired platelet function in uremia. To test this hypothesis, the function of this receptor in the platelets of 11 uremic patients was studied. Aggregation studies were performed with flow cytometric techniques with anti-GPIIb-IIIa conformation-specific monoclonal antibodies (mAb) (anti-LIBS1 and anti-PMI-1). Antifibrinogen and antithrombospondin mAb were used to characterize fibrinogen binding to GPIIb-IIIa and the release of alpha-granules, respectively. Platelets from patients with chronic renal failure showed significantly decreased binding of conformation-dependent anti-LIBS1 mAb after ADP, phorbol myristate acetate, or RGD-peptide stimulation compared with normal controls, suggesting a defect related to the ability of the fibrinogen receptor to undergo a conformational change. Moreover, antifibrinogen and antithrombospondin binding to activated platelets were reduced in uremic patients, implying impairment of both ligand- binding and alpha-granule release. Hemodialysis partially restored GPIIb-IIIa function, which may account for the observed effects of this therapy in restoring platelet aggregation. These findings indicate that platelets of patients with chronic renal failure reveal an aggregation defect at least partially due to an intrinsic GPIIb-IIIa dysfunction and the presence of a putative uremic toxin that inhibits fibrinogen binding to GPIIb-IIIa.

This article has been cited by other articles:

				C. M. Gibson, R. L. Dumaine, E. V. Gelfand, S. A. Murphy, D. A. Morrow, S. D. Wiviott, R. P. Giugliano, C. P. Cannon, E. M. Antman, E. Braunwald, et al. Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13307 patients in five TIMI trials Eur. Heart J., November 2, 2004; 25(22): 1998 - 2005. [Abstract] [Full Text] [PDF]

				R. V. Freeman, R. H. Mehta, W. Al Badr, J. V. Cooper, E. Kline-Rogers, and K. A. Eagle Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors J. Am. Coll. Cardiol., March 5, 2003; 41(5): 718 - 724. [Abstract] [Full Text] [PDF]

				J. L. Januzzi Jr, S. M. Snapinn, P. M. DiBattiste, I.-K. Jang, and P. Theroux Benefits and Safety of Tirofiban Among Acute Coronary Syndrome Patients With Mild to Moderate Renal Insufficiency: Results From the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Trial Circulation, May 21, 2002; 105(20): 2361 - 2366. [Abstract] [Full Text] [PDF]

				B. Altun, M. Arici, I. C. Haznedaroglu, C. Usalan, Y. Erdem, U. Yasavul, C. Turgan, S. Caglar, and S. Kirazli Serum thrombopoietin levels in haemodialysis patients: involvement of arteriovenous fistula Nephrol. Dial. Transplant., September 1, 1999; 14(9): 2173 - 2177. [Abstract] [Full Text] [PDF]

				A. Gries, C. Bode, K. Peter, A. Herr, H. Bohrer, J. Motsch, and E. Martin Inhaled Nitric Oxide Inhibits Human Platelet Aggregation, P-Selectin Expression, and Fibrinogen Binding In Vitro and In Vivo Circulation, April 21, 1998; 97(15): 1481 - 1487. [Abstract] [Full Text] [PDF]

				I. Ott, F.-J. Neumann, M. Gawaz, M. Schmitt, and A. Schomig Increased Neutrophil-Platelet Adhesion in Patients With Unstable Angina Circulation, September 15, 1996; 94(6): 1239 - 1246. [Abstract] [Full Text]

				M. Gawaz, F.-J. Neumann, I. Ott, A. May, and A. Schomig Platelet Activation and Coronary Stent Implantation: Effect of Antithrombotic Therapy Circulation, August 1, 1996; 94(3): 279 - 285. [Abstract] [Full Text]

				M. Gawaz, I. Ott, A. J. Reininger, U. Heinzmann, and F.-J. Neumann Agglutination of Isolated Platelet Membranes Arterioscler. Thromb. Vasc. Biol., May 1, 1996; 16(5): 621 - 627. [Abstract] [Full Text]

				M. Gawaz, F.-J. Neumann, I. Ott, A. Schiessler, and A. Schomig Platelet Function in Acute Myocardial Infarction Treated With Direct Angioplasty Circulation, January 15, 1996; 93(2): 229 - 237. [Abstract] [Full Text]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673